TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
KURA

Kura Oncology Inc

Healthcare · Biotechnology

10.70$ +0.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow KURA
Line item 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – – – – – – 249.3% -94.9%
– – – – – – – – – – – – – – – – 1.6% -11.0%
– – – – – – – – – – – – – – – – 62.9% 55.0%
– – – – – – – – – – – – – – – – 531.1% 273.3%
– – – – – – – – – – – – – – – – 0.9% 9.8%
– – – – – – – – – – – – – – – – -188.5% -19.4%
– – – – – – – – – – – – – – – – 0.0% –
– – – – – – – – – – – – – – – – 286.6% 2.7%
– – – – – – – – – – – – – – – – 347.3% -111.7%
– – – – – – – – – – – – – – – – 248.4% -104.8%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?